Skip to main content
Equibles

GABELLI FUNDS LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1081407 Rye, NY
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,616,074
+$630,168 QoQ
Shares Held
46,200
0.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#176
of 667 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GABELLI FUNDS LLC holds $57,008,523 across 31 Biotechnology names. HALO ranks #5 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 127,281 $16,894,007
2 TECH
BIO-TECHNE Corp
 189,300 $13,374,045
3 BBIO
BridgeBio Pharma, Inc.
 65,300 $4,863,544
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 7,891 $3,919,696
5 HALO
Halozyme Therapeutics, Inc.
This page 		46,200 $3,616,074
6 MRNA
Moderna, Inc.
 29,500 $2,065,885
7 INCY
Incyte Corp
 14,197 $1,609,371
8 ABVX
Abivax S.A.
 10,000 $1,332,600

All Filings in HALO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,616,074 46,200
2026-03-31 $2,985,906 46,200
2025-12-31 $7,113,610 105,700
2025-09-30 $8,965,301 122,243
2025-06-30 $6,567,160 126,243
2025-03-31 $7,413,445 116,180
2024-12-31 $5,748,817 120,243
2024-09-30 $6,424,789 112,243
2024-06-30 $6,539,764 124,900
2024-03-31 $5,085,000 125,000
2023-12-31 $4,250,400 115,000
2023-09-30 $3,447,091 90,238
2023-06-30 $3,020,429 83,738
2023-03-31 $3,197,954 83,738
2022-12-31 $1,014,299 17,826
2022-09-30 $593,100 15,000
2022-06-30 $660,000 15,000
2021-12-31 $201,050 5,000